At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Tissue Plasminogen Activatordrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quality and Effectiveness of Thrombolytic Care During Inter-hospital Transfer ("Drip-Ship") With Air Ambulance Services
In Brief
An observational study evaluating Tissue Plasminogen Activator for Stroke. Completed, enrolled 76 participants across 1 site.
Detailed Summary
Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
First PostedApr 2016
Primary CompletionOct 2017
TodayJul 2026
First PostedApr 26, 2016
Enrollment StartOct 1, 2015
Primary CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.2 years ago
Interventions
Tissue Plasminogen Activatordrug